Showing 1 to 2 of 2 results


ICH E21 Guideline Seeks to Include Pregnant and Breastfeeding Women in Drug Trials
A new guideline, ICH E21, aims to address the underrepresentation of pregnant and breastfeeding women in drug trials, which currently leads to these women being denied access to newer, more effective medications due to a lack of safety and efficacy data; this is especially relevant for conditions li...
ICH E21 Guideline Seeks to Include Pregnant and Breastfeeding Women in Drug Trials
A new guideline, ICH E21, aims to address the underrepresentation of pregnant and breastfeeding women in drug trials, which currently leads to these women being denied access to newer, more effective medications due to a lack of safety and efficacy data; this is especially relevant for conditions li...
Progress
20% Bias Score

Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.

Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.
Progress
60% Bias Score
Showing 1 to 2 of 2 results